Medical Weight Loss for Bolingbrook, Illinois Residents
Bolingbrook, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Bolingbrook through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Bolingbrook Residents Choose New Hope Weight Loss
Bolingbrook patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Illinois and beyond since 2020.
Bolingbrook is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Bolingbrook patients at home.
Although our clinic is physically in Costa Mesa, California, Bolingbrook residents receive the same physician-supervised care without leaving Illinois. We care for patients throughout Bolingbrook and the southwest Chicago suburbs of Will County. There is no distance surcharge for Bolingbrook patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Like much of Illinois, many people in Bolingbrook want a physician-supervised weight-loss option without local waitlists or unclear pricing. Pricing for Bolingbrook is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Bolingbrook patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Bolingbrook
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Bolingbrook address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Bolingbrook
How do I get treatment from Bolingbrook?
As a Bolingbrook, Illinois patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Bolingbrook?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Bolingbrook in cold-pack packaging, no lines and no drive.
How much does it cost for Bolingbrook patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Bolingbrook do you serve?
We serve patients from across Bolingbrook by telehealth, including Bolingbrook and the southwest Chicago suburbs of Will County.
Is bilingual (Spanish) telehealth care available for Bolingbrook patients?
Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Bolingbrook patients.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bolingbrook, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.